Next generation sequencing can play a role by consolidating testing to a single platform, a potential game changer for community and regional hospitals.
Precision medicine is demonstrating its potential value in the face of a second wave of coronavirus outbreak
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations
Understand the affiliations and implications of the CDC’s new SPHERES initiative for rapid SARS-CoV-2 genome sequencing.
Why gene editing technology CRISPR is getting attention as a potential testing solution amid the coronavirus pandemic.
"Don't underestimate the importance of aligning the interests of different stakeholders," says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
Study shows that the traditional approach to annual health assessments needs to change...
As innovation accelerates and evidence strengthens, CMS is recognizing the value of precision medicine diagnostic testing. Its latest decision is welcome news for hospitals and health systems, as well as patients with inherited breast or ovarian cancer...
De-identified data that hospitals and health systems share with big tech can sometimes be used to identify patients. As these types of deals grow, full transparency with patients is key...